臺灣博碩士論文加值系統

研究背景：
根據世界衛生組織2012年最新統計指出，子宮頸癌的發生在全球女性前五好發癌症中居於第四位，雖然各國實施子宮頸抹片篩檢計劃的始點不同，但皆已使篩檢率大幅提升，子宮頸癌發生率及死亡率明顯降低。我國於民國84年起，提供30歲以上的婦女每年1次免費子宮頸抹片篩檢，推動至今18年，已使國內30歲以上每3年1次的篩檢率大幅上升，子宮頸發生率及死亡率也已明顯下降，顯示子宮頸抹片篩檢之重要性。但我國70歲以上婦女的篩檢率低於其他年齡層，再加上疾病自然史之演變以及以致從65歲以上開始子宮頸癌發生率與死亡率隨著年齡的增加而上升，從而使過去篩檢率低者至老年時期罹患侵襲癌之比率較高。由於台灣地區已邁入高齡化社會，現今國人女性的平均壽命為83歲，70歲以上婦女罹患子宮頸侵襲癌的發生率又高於原位癌許多，故本研究欲探討70歲以上婦女罹患子宮頸癌與其篩檢史之相關性，以了解老年婦女子宮頸抹片篩檢情形及其影響因素，提供有關當局子宮頸癌預防保健篩檢政策之參考依據。

研究目的：
本研究之目的在探討70歲以上女性有無罹患子宮頸癌與子宮頸抹片篩檢史之相關性。

研究方法：
本研究使用「癌症登記資料檔」、「子宮頸癌篩檢登記資料檔」、「子宮頸癌防治監測中心統整之人口資料檔」及「死亡登記資料檔」進行個案選取，並採配對式病例對照研究設計(Matched case-control study)，配對年齡±2歲及居住地區。使用條件式邏輯斯迴歸模式探討子宮頸原位癌及侵襲癌之發生與篩檢史之相關性，估算勝算比及95%信賴區間。

研究結果：
在原位癌發生與否的分析當中納入3605個分析對象，其中病例組有721人，對照組有2884人；在侵襲癌發生與否的分析當中納入4555個分析對象，其中病例組有911人、對照組有3644人。經年齡及居住地區配對後，70歲以上原位癌之病例組及對照組在年齡、居住地區及都市化程度之分佈上無差異，侵襲癌配對結果亦同。在原位癌發生與否的分析當中，過去曾經接受過子宮頸抹片篩檢之婦女罹患子宮頸原位癌之相對危險性是過去未曾接受過抹片篩檢之婦女的1.40倍(95% C.I. = 1.15-1.71)，隨著篩檢間隔距離越短，婦女發生子宮頸原位癌之機會越高，也就是原位癌之罹癌相對危險性隨篩檢間隔距離呈上升之趨勢。而侵襲癌發生與否的分析當中，過去曾經接受過子宮頸抹片篩檢之婦女罹患子宮頸侵襲癌之相對危險性是過去未曾接受過抹片篩檢之婦女的0.39倍(95% C.I. = 0.36-0.46)，隨著篩檢間隔距離越短，婦女發生子宮頸侵襲癌之機會越低，也就是侵襲癌之罹癌相對危險性隨篩檢間隔距離呈下降之趨勢。

結論：
本研究結果指出，發病前距離最後一次接受抹片之間隔顯著地與子宮頸原位癌與侵襲癌之發生有關。此結果顯示提高老年婦女子宮頸抹片之篩檢率之重要性。

OBJECTIVES:
This study aims to examine the association between incidence of cervical cancer and screening history among women aged 70 and over in Taiwan.

METHODS:
The data sources were the secondary data files in Taiwan. This study uses matched case-control study to investigate the relations between cervical cancer and screening history. All new cases of cervical cancer were identified from 2006-2010 cancer registry as the study cases, and the control cases were matched by age and residential areas. The screening intervals was defined as the number of days before the date of cancer diagnosis. Odds ratio and their 95% confidence intervals of screening history were estimated to predict the risk of cervical cancer in the conditional logistic regression models.

RESULTS:
In predicting the risk of cervical carcinoma in situ, women who had been screened before had higher risks than women who never had screened (OR=1.40, 95% C.I.=1.15-1.71). And the shorter the screening intervals the higher the risk of cervical carcinoma in situ. In predicting the risk of invasive cervical cancer, women who had been screened before had higher risks than women who never had screened before (OR=0.39, 95% C.I.=0.36-0.46). And the longer the screening intervals the higher the risk of invasive cervical cancer.

CONCLUSIONS:
Screening intervals was showed to have an effect on the incidence of cervical cancer among women aged 70 and over. Measures aiming to improve the screening coverage of older women are warranted to enhance early detection of cervical cancer.

誌謝 I
論文摘要 III
Abstract V
目錄 VII
表目次 IX
圖目次 X
第一章 緒論 1
第一節 研究背景與動機 1
第二節 研究目的 3
第三節 研究重要性 4
第二章 文獻探討 5
第一節 子宮頸抹片篩檢之重要性 5
第二節 各國子宮頸抹片篩檢政策之比較 8
第三節 影響婦女接受子宮頸抹片篩檢之因素 15
第四節 婦女接受子宮頸抹片之篩檢間隔與罹癌之關係 20
第三章 研究方法 25
第一節 研究設計 26
第二節 研究架構 27
第三節 研究變項之操作型定義 28
第四節 研究對象與資料來源 30
第五節 資料處理與統計方法 34
第四章 研究結果 36
第一節 研究對象及配對因子之分佈 36
第二節 單變項分析 39
第三節 多變項分析 44
第五章 討論 49
第一節 研究發現與討論 49
第二節 研究限制 53
第三節 未來研究方向與建議 54
參考文獻 55
中文部分 55
英文部分 57

中文部分
內政部統計處(2012)。簡易生命表及平均餘命。http://www.moi.gov.tw/stat/life.aspx。取自2014/03/01。
行政院主計處（2010）。台灣地區區域分類標準。http://www.dgbas.gov.tw/ct_view. as
p?xItem=27078&ctNode=3378/區域分類.XLS。取自2014/03/01。
行政院主計處（2010）。台灣地區都會區分類。http://www.dgbas.gov.tw/ct_view.as p?
xItem=27078&ctNode=3378/都市化地區分 類.XLS。取自2014/03/01。
行政院衛生福利部國民健康署(2011)：中華民國100年子宮頸癌篩檢登記報告。台北：
行政院衛生福利部國民健康署。取自http://www.hpa.gov.tw/BHPNet/Web/Stat/Stati
sticsShow.aspx?No=201304150001/100年年報.pdf。
行政院衛生福利部國民健康署(2010)。國家癌症防治五年計劃。取自http://www.hpa. go
v.tw/BHPNet/Web/HealthTopic/TopicBulletin.aspx?No=201009170001&parentid=200712250030/ 國民健康局-國家癌症防治五年計畫.pdf。
王本仁、黃心苑、周穎政、李丞華、張鴻仁(2005)。全民健保子宮頸抹片檢查受檢情形影響因子分析—個體時間序列資料之實證研究，1997~ 2000。臺灣公共衛生雜誌，24(1)，33-42。
李翠鳳、郭旭崧、陳錫中、陳天順、周碧瑟(1997)。金門縣婦女子宮頸防癌抹片檢查的影響因素。中華衛誌，16(3)，198-210。
林惠賢、王琳華、劉淑敏、康啟杰(2003)。屏東地區婦女接受子宮頸抹片檢查之相關因素。臺灣公共衛生雜誌，22(2)，127-133。
林麗珠(2003)。衛生教育介入對婦女參與子宮頸抹片檢查意願與行為影響之研究─以台南縣後壁鄉為例。高雄醫學大學公共衛生學系碩士論文。
施鈞偉(2008)。都市化程度與居民健康:以台灣地區為例。成功大學公共衛生研究所學位論文。
徐偉宏、郭平欣(2008)。子宮頸抹片篩檢“認知”與“利用”的影響因素分析－雙元普羅比模型之實證研究。台灣衛誌，27(3)， 231-242。
許雅筑(2013)。子宮頸抹片篩檢與子宮頸侵襲癌發生與存活的社經差異之研究。國立成功大學公共衛生研究所碩士論文。
陳松吟(2003)。全民健康保險子宮頸癌抹片篩檢使用型態六年之追蹤研究。國立陽明大學衛生福利研究所碩士論文。
陳美如(2005)。由國外經驗檢視我國子宮頸癌篩檢政策。國立台灣大學衛生政策與管理研究所碩士論文。
陳慈怡、李嬿如、游山林、陳建仁、謝長堯、陳素秋(2005)。全民健保實施前後影響子
宮頸抹片篩檢之因素及成果。台灣衛誌，24（5）：440-451。
黃月桂、葉明義、林琴豐(1998)。全民健康保險子宮頸抹片檢查之利用度研究。中華衛誌，17(1)，28-35。
劉培懿(2004)。婦女感染人類乳突狀病毒之危險因素分析。高雄醫學大學護理學研究所碩士論文。
賴美淑(2011)。台灣癌症登記發展與沿革。聲洋防癌之聲，132，35-9。
簡大任、季瑋珠(1995)。台北市有偶婦女接受子宮頸抹片檢查影響因素之探討。中華衛誌，14(2)，111-128。
 
英文部分
Andrae, B., Kemetli, L., Sparen, P., Silfverdal, L., Strander, B., Ryd, W., Ryd, W., Tornberg, S. (2008). Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst, 100(9), 622-629.
Anttila, A., Ronco, G., Clifford, G., Bray, F., Hakama, M., Arbyn, M., & Weiderpass, E. (2004). Cervical cancer screening programmes and policies in 18 European countries. British Journal of Cancer, 91(5), 935-941.
Anttila, A., & Ronco, G. (2009). Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer, 45(15), 2685-2708.
Ballegooijen, M. v., Marle, E. v. d. A.-v., Patnick, J., Lynge, E., Arbyn, M., Anttila, A., Ronco, G., Habbema, J. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. European Journal of Cancer, 36(17), 2177-2188.
Beral, V. (1974). Cancer of the cervix: a sexually transmitted infection?. The
Lancet, 303(7865), 1037-1040.
Bos, A. B., Rebolj, M., Habbema, J. D., & van Ballegooijen, M. (2006). Nonattendance is still
the main limitation for the effectiveness of screening for cervical cancer in the
Netherlands. Int J Cancer, 119(10), 2372-2375.
Bray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Moller, H., Hakama, M., &
Parkin, D. M. (2005). Trends in cervical squamous cell carcinoma incidence in 13
European countries: changing risk and the effects of screening. Cancer Epidemiology
Biomarkers & Prevention, 14(3), 677-686.
Canadian Cancer Society’s Steering Committee on Cancer Statistics(2011). Canadian cancer statistics 2011. Canadian Cancer Society, Toronto.
Cheek, J., Fuller, J., Gilchrist, S., Maddock, A., & Ballantyne, A. (1999). Vietnamese women and Pap smears: issues in promotion. Australian and New Zealand journal of public health, 23(1), 72-76.
Clarke, E. A., & Anderson, T. (1979). DOES SCREENING BY "PAP" SMEARS HELP PREVENT CERVICAL CANCER? The Lancet, 314(8132), 1-4.
Coughlin, S. S., King, J., Richards, T. B., & Ekwueme, D. U. (2006). Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev,15(11), 2154-2159.
Damiani, G., Federico, B., Basso, D., Ronconi, A., Bianchi, C. B., Anzellotti, G. M., Nasi, G., Sassi, F., & Ricciardi, W. (2012). Socioeconomic disparities in the uptake of breast and cervical cancer screening in Italy: a cross sectional study. BMC Public Health, 12(1), 99.
Datta, G. D., Colditz, G. A., Kawachi, I., Subramanian, S. V., Palmer, J. R., & Rosenberg, L. (2006). Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis. Cancer, 106(3), 664-669.
Dickinson, J. A., Stankiewicz, A., Popadiuk, C., Pogany, L., Onysko, J., & Miller, A. B. (2012). Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006. BMC Public Health, 12, 992.
Dollin. (2013). Recommendations on screening for cervical cancer. Canadian Medical Association Journal, 185(1), 35-45.
Eaker, S., Adami, H. O., & Sparen, P. (2001). Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med, 32(6), 482-491.
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W., Comber, H., Forman, D., & Bray, F. (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49(6), 1374-1403.
Fidler, H. K., Boyes, D. A., & Worth, A. J. (1968). Cervical cancer detection in British Columbia. BJOG: An International Journal of Obstetrics & Gynaecology. 75(4), 392-404.
Franco, E. L., & Ferenczy, E. D.-F. A. (2001). Cervical cancer:epidemiology, prevention and the role of human papillomavirus infection. CMAJ, 164(7), 1017-1025.
Hancock, L., Sanson-Fisher, R., Perkins, J., Corkrey, R., Burton, R., & Reid, S. (2001). Effect of a Community Action Intervention on Cervical Cancer Screening Rates in Rural Australian Towns: The CART Project. Prev Med, 32(2), 109-117.
Haverkos, H., Rohrer, M., & Pickworth, W. (2000). The cause of invasive cervical cancer could be multifactorial. Biomedicine & Pharmacotherapy, 54(1), 54-59.
Hiatt, R. A., Pasick, R. J., Stewart, S., Bloom, J., Davis, P., Gardiner, P., Johnston, M., Luce, J., Schorr, K., Brunner, W., & Stroud, F. (2001). Community-Based Cancer Screening for Underserved Women: Design and Baseline Findings from the Breast and Cervical Cancer Intervention Study. Prev Med, 33(3).
Hoffman M, Cooper D, & Carrara H. (2003). Limited Pap screening associated with reduced risk of cervical cancer in South Africa. International Journal of Epidemiology, 32(4), 573-577.
Hsia, J., Kemper, E., Kiefe, C., Zapka, J., Sofaer, S., Pettinger, M., Bowen, D., Limacher, M., Lillington, L., & Mason, E. (2000). The importance of health insurance as a determinant of cancer screening: evidence from the Women''s Health Initiative. Preventive medicine, 31(3), 261-270.
Ibfelt, E., Kjaer, S. K., Johansen, C., Hogdall, C., Steding-Jessen, M., Frederiksen, K., Frederiksen, B. L., Osler, M., & Dalton, S. O. (2012). Socioeconomic position and stage of cervical cancer in Danish women diagnosed 2005 to 2009. Cancer Epidemiol Biomarkers Prev, 21(5), 835-842.
Kanar, & G., S. (1998). Management of abnormal Papanicolaou smears: A review. Primary care update for ob/gyns, 5(2), 95-100.
Karsa, L. V., Anttila, A., Ronco, G., Ponti, A., Malila, N., Arbyn, M., ... & Autier, P. (2008).
Cancer screening in the European Union. Report on the implementation of the Council
Recommendation on cancer screening. Cancer screening in the European Union.
Report on the implementation of the Council Recommendation on cancer screening.
Lee-Lin, F., Marjorie Pett, Menon, U., Lee, S., Nail, L., Mooney, K., & Itano, J. (2007).
Cervical Cancer Beliefs and Pap Test Screening Practices Among Chinese American
Immigrants. Oncology Nursing Forum, 34(6), 1203-1209.
Lee, F. H. M., RN, & Wang, H. H. P., RN, FAAN. (2011). The Utilization of Pap Test Services
of Women: A Nationwide Study in Taiwan. Cancer Nursing, 34(6), 464-469.
Leung, G. M., Woo, P. P., Cowling, B. J., Tsang, C. S., Cheung, A. N., Ngan, H. Y., Ngan, H. SY. S., Galbraith K., Lam, & T. H. (2008). Who receives, benefits from and is harmed by cervical and breast cancer screening among Hong Kong Chinese? J Public Health (Oxf), 30(3), 282-292.
Linos, A., & Riza, E. (2000). Comparisons of cervical cancer screening programmes in the
European Union. European Journal of Cancer, 36(17), 2260-2265.
Lonnberg, S., Anttila, A., Luostarinen, T., & Nieminen, P. (2012). Age-specific effectiveness
of the Finnish cervical cancer screening programme. Cancer Epidemiol Biomarkers
Prev, 21(8), 1354-1361. doi: 10.1158/1055-9965.EPI-12-0162
Lonnberg, S., Nieminen, P., Luostarinen, T., & Anttila, A. (2013). Mortality audit of the Finnish cervical cancer screening program. Int J Cancer, 132(9), 2134-2140.
Mandelblatt, J. S., & Fahs, M. C. (1988). The cost-effectiveness of cervical cancer screening
for low-income elderly women. Jama, 259(16), 2409-2413.
Paskett, E. D., McMahon, K., Tatum, C., Velez, R., Shelton, B., Case, L. D., Wofford, J.,
Moran, W., & Wymer, A. (1998). Clinic-based interventions to promote breast and
cervical cancer screening. Preventive medicine, 27(1), 120-128.
Rostad, B., Schei, B., & Costa, F. da.(2003). Risk factors for cervical cancer in Mozambican women. International Journal of Gynecology and Obstetrics, 80(1), 63-65.
Sasieni, P., Castanon, A., & Cuzick, J. (2009). Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ, 339, b2968.
Sawaya, G. F., Kerlikowske, K., Lee, N. C., Gildengorin, G., & Washington, A. E. (2000). Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstetrics & Gynecology, 96(2), 219-223.
Shack, L., Jordan, C., Thomson, C. S., Mak, V., & Moller, H. (2008). Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC cancer, 8(1), 271.
Sung, H.-Y., Kearney, K. A., Miller, M., Kinney, W., Sawaya, G. F., & Hiatt, R. A. (2000). Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer, 88(10), 2283-2289.
Van Ballegooijen, M., Koopmanschap, M. A., & Habbema, J. D. F. (1995). The management
of cervical intra-epithelial neoplasia (CIN): extensiveness and costs in The
Netherlands. European Journal of Cancer, 31(10), 1672-1676.
Villa, L. L. (2012). Cervical cancer in Latin America and the Caribbean: the problem and the way to solutions. Cancer Epidemiol Biomarkers Prev, 21(9), 1409-1413.
Wang, P., & Lin, R. (1996). Sociodemographic factors of Pap smear screening in Taiwan. Public Health, 110(2), 123-127.
Wu, Z. H., Black, S. A., & Markides, K. S. (2001). Prevalence and associated factors of
cancer screening: why are so many older Mexican American women never
screened?. Preventive Medicine, 33(4), 268-273.
Zareen, A., Kouser, S., Begum, A., & Tabassum, Z. (2009). Cervical Screening Awareness and
Practice among Medical Personnel. Journal of South Asian Federation of Obstetrics
& Gynecology, 1(2), 34-37.